Clinical Trial Update: MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a maintenance immunosuppression regimen consisting of mycophenolate mofetil, daclizumab, and corticosteroids in kidney …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Corticosteroids (corticosteroids)
• Daclizumab (daclizumab)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Ekberg, Henrik, M.D. | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED